2 - 4 October | Copenhagen, Denmark

ISSCR iPSC-derived cell therapies

 Pluripotent stem cell-derived cell therapies are accelerating rapidly into clinical trials. The ISSCR, in partnership with Novo Nordisk, will gather pioneers at the forefront of ESC and iPSC-derived cell therapies-renowned scientists and innovators will share the latest updates on ongoing clinical trials, as well as groundbreaking platforms and technologies that will revolutionise the next generation of cell therapies
ISSCR iPSC-derived cell therapies
 Pluripotent stem cell-derived cell therapies are accelerating rapidly into clinical trials. The ISSCR, in partnership with Novo Nordisk, will gather pioneers at the forefront of ESC and iPSC-derived cell therapies-renowned scientists and innovators will share the latest updates on ongoing clinical trials, as well as groundbreaking platforms and technologies that will revolutionise the next generation of cell therapies

We are sponsoring this event!

Come and visit our team at our stand to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.

More information coming soon!

Arrange a meeting

Related pages

News Read our latest updates and press coverage
Blog Learn more about cells, our products, company and culture
About us Find out more about us and our people